Cargando…
Genetic modifiers regulating DNA replication and double strand break repair are associated with differences in mammary tumors in mouse models of Li-Fraumeni Syndrome
Breast cancer is the most common tumor among women with inherited variants in the TP53 tumor suppressor, but onset varies widely suggesting interactions with genetic or environmental factors. Rodent models haploinsufficent for Trp53 also develop a wide variety of malignancies associated with Li-Frau...
Autores principales: | Majhi, Prabin Dhangada, Griner, Nicholas B., Mayfield, Jacob A., Compton, Shannon, Kane, Jeffrey J., Baptiste, Trevor A., Dunphy, Karen A., Roberts, Amy L., Schneider, Sallie S., Savage, Evan M., Patel, Divyen, Blackburn, Anneke C., Maurus, Kim Joana, Wiesmüller, Lisa, Jerry, D. Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349885/ https://www.ncbi.nlm.nih.gov/pubmed/34183771 http://dx.doi.org/10.1038/s41388-021-01892-5 |
Ejemplares similares
-
Genetic modifiers of p53: opportunities for breast cancer therapies
por: Majhi, Prabin Dhangada, et al.
Publicado: (2023) -
Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017) -
Effects of Benzophenone-3 and Propylparaben on Estrogen Receptor–Dependent R-Loops and DNA Damage in Breast Epithelial Cells and Mice
por: Majhi, Prabin Dhangada, et al.
Publicado: (2020) -
Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in the Li-Fraumeni Syndrome model, Trp53(+/-) mice
por: Blackburn, Anneke C, et al.
Publicado: (2014) -
Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019)